Weaver Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,222
Closed -$655K 182
2025
Q4
$655K Sell
6,222
-4,833
-44% -$454K 0.14% 126
2025
Q3
$928K Sell
11,055
-1,434
-11% -$118K 0.2% 102
2025
Q2
$989K Sell
12,489
-959
-7% -$76.2K 0.24% 94
2025
Q1
$1.21M Sell
13,448
-2,891
-18% -$270K 0.32% 81
2024
Q4
$1.63M Buy
16,339
+1,011
+7% +$104K 0.45% 62
2024
Q3
$1.74M Sell
15,328
-5,161
-25% -$613K 0.52% 55
2024
Q2
$2.54M Sell
20,489
-643
-3% -$82.8K 0.82% 33
2024
Q1
$2.79M Buy
21,132
+4,303
+26% +$530K 0.95% 23
2023
Q4
$1.83M Buy
+16,829
New +$1.75M 0.73% 42

Other funds holding MRK

Weaver Capital Management's MRK Position: Q1 2026 in Review

Weaver Capital Management sold out of Merck (MRK) in Q1 2026, closing a stake of 6,222 shares — an estimated $655K sold.

Weaver Capital Management first reported a position in MRK in Q4 2023 and held it in 9 quarters. The position peaked at $2.79M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Weaver Capital Management reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Weaver Capital Management sold 6,222 Merck shares in Q1 2026, an estimated $655K.
  • Weaver Capital Management first reported a position in Merck in Q4 2023 and held it in 9 quarters.
  • Weaver Capital Management's Merck position peaked at $2.79M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Weaver Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.